Dysbiosis in inflammatory bowel disease

Tamboli C P; Neut C; Desreumaux P; Colombel J F
January 2004
Gut;Jan2004, Vol. 53 Issue 1, p1
Academic Journal
Abundant data have incriminated intestinal bacteria in the initiation and amplification stages of inflammatory bowel diseases. However, the precise role of intestinal bacteria remains elusive. One theory has suggested a breakdown in the balance between putative species of "protective" versus "harmful" intestinal bacteria--this concept has been termed "dysbiosis". Arguments in support of this concept are discussed.


Related Articles

  • Inflammatory bowel disease: dysfunction of GALT and gut bacterial flora (II). Chandran, P.; Satthaporn, S.; Eremin, O.; Robins, A. // Surgeon (Edinburgh University Press);Jun2003, Vol. 1 Issue 3, p125 

    Presents a study which explored the various environmental and microbial factors that have been implicated and their relationship in the pathogenesis of inflammatory bowel disease (IBD). Commensal bacteria and the development of gut-associated lymphoid tissue; Key component of the pathogenesis...

  • Role of alkaline phosphatase in colitis in man and rats. A Tuin // Gut;Mar2009, Vol. 58 Issue 3, p379 

    BACKGROUND AND AIMS: Crohn’s disease (CD) and ulcerative colitis (UC) are chronic multifactorial inflammatory bowel diseases (IBDs) with unknown aetiology, but a deregulated mucosal immune response to gut-derived bacterial antigens is thought to be involved. Toll-like receptor ligands,...

  • Molecular prediction of disease risk and severity in a large Dutch Crohn’s disease cohort. R K Weersma // Gut;Mar2009, Vol. 58 Issue 3, p388 

    BACKGROUND: Crohn’s disease and ulcerative colitis have a complex genetic background. We assessed the risk for both the development and severity of the disease by combining information from genetic variants associated with inflammatory bowel disease (IBD). METHODS: We studied 2804...

  • Inflammatory Bowel Disease in Kuwait. Al-Nakib, B.; Radhakrishnan, S.; Jacob, G. S.; Al-Liddawi, H.; Al-Ruwaih, A. // American Journal of Gastroenterology;Mar1984, Vol. 79 Issue 3, p191 

    Inflammatory bowel disease is considered to be rare or nonexistent in some Arab countries. During a period of 6 years, 91 patients with ulcerative colitis and 17 with Crohn's disease were seen for initial diagnosis in the Gastroenterology Department of Amiri Hospital, which serves 55% of the...

  • World Gastroenterology Organisation Global Guideline: Inflammatory bowel disease: a global perspective - June 2009. Bernstein, Charles N.; Fried, Michael; Krabshuis, J. H.; Cohen, Henry; Eliakim, R.; Fedail, Suleiman; Gearry, Richard; Goh, K. L.; Hamid, Saheed; Khan, Aamir Ghafor; LeMair, A. W.; Malfertheiner, P.; Qin Ouyang; Rey, J.-F.; Sood, Ajit; Steinwurz, Flavio; Thomsen, Ole �.; Thomson, Alan; Watermeyer, Gillian // South African Gastroenterology Review;Aug2010, Vol. 8 Issue 2, p13 

    The article presents the global guideline for inflammatory bowel disease (IBD) from the World gastroenterology Organisation. It notes that IBD contains a group of idiopathic chronic inflammatory intestinal illnesses which has two main disease types such as Crohn's disease (CD) and ulcerative...

  • Acute distal colitis impairs gastric emptying in rats via an extrinsic neuronal reflex pathway involving the pelvic nerve. De Schepper, H. U.; De Man, I. G.; Van Nassauw, I.; Timmermans, J.-P.; Herman, A. G.; Pelckmans, P. A.; De Winter, B. Y. // Gut;Feb2007, Vol. 56 Issue 2, p195 

    Background and aims: Patients with inflammatory bowel disease often present with abnormal gut motility away from the inflammatory site. We studied remote motility disturbances and their pathophysiology in a rat model of colitis. Methods: Colitis was induced 72 h prior to experiments using...

  • Dual Effect of Butyrate on IL�1 � � Mediated Intestinal Epithelial Cell Inflammatory Response. Blais, Myl�ne; Seidman, Ernest G.; Asselin, Claude // DNA & Cell Biology;Mar2007, Vol. 26 Issue 3, p133 

    Butyrate (NaBu), a product of intestinal microbial metabolism, has been proposed as an anti-inflammatory agent for treating inflammatory bowel diseases. However, the molecular mechanisms implicated in the modulation of intestinal epithelial cell inflammatory response to NaBu remain unknown....

  • Probiotic therapy in gut.  // GP: General Practitioner;10/1/2004, p19 

    This article reports the results of a study, conducted by researchers at Dundee University, which states that a pro-biotic therapy, which raises levels of "good bacteria" in the gut, may help reduce symptoms of inflammatory bowel disease. Researchers analyzed the populations of micro flora in...

  • Severe IBS and mental health issues. Whorwell, Peter // Pulse;9/10/2005, Vol. 65 Issue 35, p61 

    Discusses the etiology and severity of inflammatory bowel diseases (IBS). Analysis of the physiological and psychological aspects of IBS; Association of IBS with an increased risk of suicidal ideation; Treatment and management of the disease.


Read the Article


Sign out of this library

Other Topics